Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) EBITDA (2016 - 2025)

Historic EBITDA for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $40.1 million.

  • Bio-Techne's EBITDA rose 32950.57% to $40.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $104.4 million, marking a year-over-year decrease of 2331.14%. This contributed to the annual value of $91.8 million for FY2025, which is 4107.52% down from last year.
  • Bio-Techne's EBITDA amounted to $40.1 million in Q4 2025, which was up 32950.57% from $33.7 million recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's EBITDA ranged from a high of $84.9 million in Q4 2021 and a low of $4.5 million during Q2 2025
  • Moreover, its 5-year median value for EBITDA was $41.6 million (2022), whereas its average is $46.9 million.
  • Data for Bio-Techne's EBITDA shows a peak YoY increase of 32950.57% (in 2025) and a maximum YoY decrease of 8804.12% (in 2025) over the last 5 years.
  • Over the past 5 years, Bio-Techne's EBITDA (Quarter) stood at $84.9 million in 2021, then decreased by 21.46% to $66.7 million in 2022, then crashed by 37.29% to $41.8 million in 2023, then plummeted by 77.7% to $9.3 million in 2024, then surged by 329.51% to $40.1 million in 2025.
  • Its EBITDA stands at $40.1 million for Q4 2025, versus $33.7 million for Q3 2025 and $4.5 million for Q2 2025.